Bempegaldesleukin plus nivolumab versus sunitinib or cabozantinib in previously untreated advanced clear cell renal cell carcinoma: a phase III randomized study (PIVOT-09)

Nizar M. Tannir*, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A. Tagliaferri, Daniel George, Neeraj Agarwal, Sumanta Kumar Pal, List of investigators

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Bempegaldesleukin plus nivolumab versus sunitinib or cabozantinib in previously untreated advanced clear cell renal cell carcinoma: a phase III randomized study (PIVOT-09)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science